Schonfeld Strategic Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
15,514
-52,800
| -77% | -$595K | ﹤0.01% | 1709 |
|
|
2025
Q1 | $689K | Sell |
68,314
-3,086
| -4% | -$31.1K | ﹤0.01% | 1330 |
|
|
2024
Q4 | $845K | Sell |
71,400
-283,295
| -80% | -$3.35M | ﹤0.01% | 1130 |
|
|
2024
Q3 | $4.09M | Buy |
354,695
+233,377
| +192% | +$2.69M | 0.03% | 510 |
|
|
2024
Q2 | $1.28M | Sell |
121,318
-662,449
| -85% | -$7M | 0.01% | 975 |
|
|
2024
Q1 | $8.26M | Buy |
783,767
+699,227
| +827% | +$7.37M | 0.05% | 389 |
|
|
2023
Q4 | $949K | Buy |
+84,540
| New | +$949K | 0.01% | 984 |
|
|
2023
Q1 | – | Sell |
-303,215
| Closed | -$2.42M | – | 2459 |
|
|
2022
Q4 | $2.42M | Buy |
+303,215
| New | +$2.42M | 0.02% | 742 |
|
|
2022
Q2 | – | Sell |
-43,500
| Closed | -$215K | – | 2814 |
|
|
2022
Q1 | $215K | Buy |
+43,500
| New | +$215K | ﹤0.01% | 1843 |
|